. "Appendix C Information-Gathering Meeting Agendas." The Anthrax Vaccine: Is It Safe? Does It Work?. Washington, DC: The National Academies Press, 2002.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
The Anthrax Vaccine: Is it Safe? Does it Work?
Meeting II
January 29–30, 2001
The Foundry Building
1055 Thomas Jefferson Street, NW
Washington, DC
Meeting Objectives
Review several completed studies of anthrax vaccine safety and efficacy
Evaluate knowledge of vaccine components
Define needs for additional information gathering
Plan future meetings
Agenda
Monday, January 29, 2001
12:00 p.m.
Open Session
A review of some of the studies of the anthrax vaccine
12:00
The CDC Observational Study
Dr. Juli Clifford, Center for Biologics Evaluation and Research, FDA
12:30
Components of the Anthrax Vaccine Absorbed and Contrast with Merck Vaccine
Dr. Robert Myers, BioPort Corporation
1:00
Working lunch
1:30
Field Evaluation of a Human Anthrax Vaccine
Dr. Stanley Plotkin
2:00
Ft. Detrick Multi-Dose, Multi-Vaccine Safety Studies
LTC Phillip Pittman, U.S. Army Medical Research Institute of Infectious Diseases
